Viscosupplementation Market - Top Companies and Manufacturers

Companies Dominating the Viscosupplementation System Landscape

Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Anika Therapeutics, Inc.
Seikagaku Corporation
Smith & Nephew PLC
Lifecore Biomedical, Inc.
LG Chem Life Sciences Innovation Center, Inc.
Fidia Farmaceutici S.p.A.
F. Hoffmann-La Roche Ltd
Chugai Pharmaceutical Co., Ltd.
OrthogenRx, Inc.

Browse Key Market Insights with Data Illustration:

Viscosupplementation Market Size & Share, Forecast Report 2037

In the News

Chugai Pharmaceutical Co., Ltd. has obtained regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) for its osteoporosis treatment Edirol Tablets 0.5 g/0.75 g (generic name: eldecalcitol, hereafter, Edirol Tablet), a vitamin D3 derivative developed by Chugai based on long-standing research into vitamin D.
Seikagaku Corporation launched HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Taiwan, through TCM Biotech International Corp. The main ingredient of HyLink is a cross-linked hyaluronate hydrogel derived from Seikagaku's crosslinking technology.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of viscosupplementation is assessed at USD 5.13 billion.

The viscosupplementation market size was over USD 4.78 billion in 2024 and is set to reach USD 14.96 billion by the end of 2037, growing at around 9.1% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population and high prevalence of obesity will boost the market growth.

North America industry is projected to account for majority revenue share by of 2037, owing to increasing geriatric population, escalating preference for short treatment schedules, and the growing occurrence of osteoarthritis in the region.

The major players in the market include Sanofi S.A., Anika Therapeutics, Inc., Seikagaku Corporation, Smith & Nephew PLC, Lifecore Biomedical, Inc., LG Chem Life Sciences Innovation Center, Inc., Fidia Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd, Chugai Pharmaceutical Co., Ltd., OrthogenRx, Inc.

Viscosupplementation Market - Top Companies and Manufacturers

Companies Dominating the Viscosupplementation System Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the viscosupplementation market worth?

Why is the demand for viscosupplementation growing?

Which region dominated the majority of viscosupplementation industry share?

Who are the top viscosupplementation companies?